Improving Antibody Production in Chicken Oviduct Cells
Author Information
Author(s): Oishi Isao, Kim Sungtae, Yoshii Kyoko, Esteban Concepcion Rodriguez, Izpisua Belmonte Juan Carlos
Primary Institution: Health Research Institute, National Institute of Advanced Industrial Science and Technology
Hypothesis
Can the Cre/loxP system enhance the expression of monoclonal antibodies in chicken oviduct cells using an ovalbumin promoter?
Conclusion
The Cre/loxP-based system significantly increases the production of therapeutic monoclonal antibodies in chicken oviduct cells.
Supporting Evidence
- The expression level of hIgG in oviduct cells was increased 40-fold compared to that induced directly by the ovalbumin promoter.
- hIgG was not induced by the ovalbumin promoter-driven Cre in chicken embryonic fibroblast cells.
- The study demonstrated that the Cre/loxP system could enhance protein production specifically in oviduct cells.
Takeaway
Scientists found a way to make chickens produce more medicine by using a special system that helps control when the medicine is made in the chicken's egg whites.
Methodology
The study used a Cre/loxP-mediated conditional excision system to enhance the expression of humanized immunoglobulin G in chicken oviduct cells.
Limitations
The effectiveness of the system in transgenic chickens remains to be demonstrated.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website